Literature DB >> 29414822

Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma.

Bai-Hui Liu1,2, Bin-Bin Zhang1,2, Xiang-Qi Liu1,2, Shan Zheng1,2, Kui-Ran Dong1,2, Rui Dong1,2.   

Abstract

BACKGROUND/AIMS: Hepatoblastoma is the most common malignant pediatric liver cancer. circular RNAs (circRNAs) play important roles in fine-tuning gene expression and are often deregulated in cancers. However, the expression profile and clinical significance of circRNAs in hepatoblastoma is still unknown.
METHODS: Circular RNA microarray was conducted to identify hepatoblastoma-related circRNAs. GO analysis, pathway analysis, and miRNA response elements analysis was conducted to predict the potential roles of differentially expressed circRNAs in hepatoblastoma. MTT assays, Ki67 staining, and Transwell assays were conducted to clarify the role of circRNA in hepatoblastoma in vitro. Bioinformatics analysis and in vitro experiments were conducted to clarify the mechanism of circRNA-mediated gene regulation in hepatoblastoma cell.
RESULTS: 869 differentially expressed circRNAs were identified between hepatoblastoma and adjacent normal liver samples, including 421 up-regulated circRNAs and 448 down-regulated circRNAs. The significant enriched GO term of hepatoblastoma-related circRNAs in biological process, cellular component, and molecular function were "chromosome organization", "cytoplasm", and "organic cyclic compound binding". Tight junction signaling pathway was ranked the Top 1 potentially affected by circRNA-mediated regulatory network. circ_0015756 was significantly up-regulated in human hepatoblastoma specimens and metastatic hepatoblastoma cell lines. circ_0015756 silencing decreased hepatoblastoma cell viability, proliferation, and invasion in vitro. circ_0015756 acted as miR-1250-3p sponge to regulate hepatoblastoma cell function.
CONCLUSIONS: circRNAs are involved in the pathogenesis of hepatoblastoma. circ_0015756 is a promising target for the prognosis, diagnosis, and treatment of hepatoblastoma.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Circular RNA; Hepatoblastoma; MicroRNA sponge

Mesh:

Substances:

Year:  2018        PMID: 29414822     DOI: 10.1159/000487163

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  11 in total

1.  Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610.

Authors:  Weisheng Guo; Lin Zhao; Guangya Wei; Peng Liu; Yu Zhang; Liran Fu
Journal:  Cancer Manag Res       Date:  2020-08-18       Impact factor: 3.989

2.  Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma.

Authors:  Shuping Zhou; Juan Wei; Yeliu Wang; Xinkuang Liu
Journal:  Exp Ther Med       Date:  2020-02-12       Impact factor: 2.447

3.  Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.

Authors:  Ling Liu; Xin Yang; Nian-Feng Li; Ling Lin; Hui Luo
Journal:  Cell Cycle       Date:  2019-09-16       Impact factor: 4.534

Review 4.  Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.

Authors:  Sen Han; Ting Zhang; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul; Zhihong Yang
Journal:  J Investig Med       Date:  2020-08-24       Impact factor: 3.235

5.  CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis.

Authors:  Ni Zhen; Song Gu; Ji Ma; Jiabei Zhu; Minzhi Yin; Min Xu; Jing Wang; Nan Huang; Zhongqi Cui; Zhixuan Bian; Fenyong Sun; Qiuhui Pan
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

6.  Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.

Authors:  Yanfeng Liu; Jianping Song; Yu Liu; Zhipeng Zhou; Xianqiang Wang
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

Review 7.  Tight junctions and their regulation by non-coding RNAs.

Authors:  Xiaojiao Zhao; Hongliang Zeng; Li Lei; Xiaoliang Tong; Lun Yang; Yan Yang; Si Li; Ying Zhou; Liping Luo; Jinhua Huang; Rong Xiao; Jing Chen; Qinghai Zeng
Journal:  Int J Biol Sci       Date:  2021-01-31       Impact factor: 6.580

8.  circ-CFH promotes the development of HCC by regulating cell proliferation, apoptosis, migration, invasion, and glycolysis through the miR-377-3p/RNF38 axis.

Authors:  Zengyin Chen; Juan Du; Chen Yang; Guangju Si; Yuxin Chen
Journal:  Open Life Sci       Date:  2022-03-23       Impact factor: 0.938

Review 9.  The function and regulation network mechanism of circRNA in liver diseases.

Authors:  Panpan Wang; Yunhuan Zhang; Lugang Deng; Zhi Qu; Peisen Guo; Limin Liu; Zengli Yu; Peixi Wang; Nan Liu
Journal:  Cancer Cell Int       Date:  2022-03-31       Impact factor: 5.722

10.  circRNA-TBC1D4, circRNA-NAALAD2 and circRNA-TGFBR3: Selected Key circRNAs in Neuroblastoma and Their Associations with Clinical Features.

Authors:  Weihong Lin; Zuopeng Wang; Jing Wang; Hanlei Yan; Qilei Han; Wei Yao; Kai Li
Journal:  Cancer Manag Res       Date:  2021-05-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.